Latha Vairavan
SVP Chief Financial Officer · 4 filings · Latest: May 11, 2026
Arcutis Biotherapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ARQT | Latha Vairavan | SVP Chief Financial Officer | May 11, 2026 | Sale | $21.05 | 435 | $9.2K | 85,978 | |
ARQT | Latha Vairavan | — | May 11, 2026 | Proposed Sale | $21.05 | 435 | $9.2K | — | |
ARQT | Latha Vairavan | SVP Chief Financial Officer | May 4, 2026 | Sale | $23.61 | 1,341 | $31.7K | 86,413 | |
ARQT | Latha Vairavan | — | May 4, 2026 | Proposed Sale | $23.61 | 1,341 | $31.7K | — | |
ARQT | Latha Vairavan | SVP Chief Financial Officer | Mar 2, 2026 | Sale | $25.18 | 2,853 | $71.8K | 87,754 | |
ARQT | Latha Vairavan | — | Mar 2, 2026 | Proposed Sale | $25.18 | 2,853 | $71.8K | — | |
ARQT | Latha Vairavan | SVP Chief Financial Officer | Feb 2, 2026 | Sale | $25.50 | 1,320 | $33.7K | 63,607 | |
ARQT | Latha Vairavan | — | Feb 2, 2026 | Proposed Sale | $25.50 | 1,320 | $33.7K | — | |
ARQT | Latha Vairavan | — | Nov 3, 2025 | Proposed Sale | $24.72 | 88 | $2.2K | — | |
ARQT | Vairavan Latha | — | Aug 4, 2025 | Proposed Sale | $14.10 | 89 | $1.3K | — |